Welcome to our dedicated page for Dror Ortho-Design news (Ticker: DROR), a resource for investors and traders seeking the latest updates and insights on Dror Ortho-Design stock.
Dror Ortho-Design develops ZSmile, an AI-powered orthodontic platform that uses pulsating air delivered through a single custom-made smart aligner to straighten teeth. Company news centers on regulatory clearances and approvals, including FDA 510(k) clearance and Israeli medical-device authorization, as well as product usability work, remote monitoring features, and clinician-facing initiatives.
Recurring updates also cover ZSmile’s app-based treatment management, IoT connectivity, cloud analytics, production and development partnerships, and comparisons with traditional multi-tray aligner systems. Governance, operating results, and regulatory disclosures form additional recurring categories for the OTC Pink-listed company.
Dror Ortho-Design (OTC PINK: DROR) announced FDA 510(k) clearance for its next‑generation ZSmile Platform on February 19, 2026, enabling a phased U.S. commercial launch.
ZSmile uses proprietary pulsating air pneumatic tooth‑movement in a single IoT‑connected smart aligner, was tested in >300 patients, and previously received CE marking and Israeli approval.
Dror (OTC PINK: DROR) announced that its second‑generation ZSmile platform received regulatory approval from the Israeli Ministry of Health AMAR division, clearing the way for a 2026 launch in Israel as a precursor to planned rollouts in the U.S. and Europe. ZSmile is a smart nighttime appliance using proprietary pulsating air technology to correct smiles overnight and includes a companion mobile app for real‑time monitoring and patient‑doctor communication. Management said the device aligns with treatment criteria validated in prior FDA‑ and CE‑cleared clinical trials and that the company will continue pursuing U.S. FDA and EU MDR clearances.
Dror Ortho-Design (OTC PINK: DROR) has launched the ZSmile Innovation Network, a global initiative aimed at transforming orthodontic treatment. The company's breakthrough technology offers overnight smile correction, addressing major limitations of traditional aligners revealed in their survey of 1,000 users where 86% reported daily activity interference and 77% experienced discomfort.
The ZSmile platform utilizes innovative pulsating air technology through a single smart aligner worn during sleep, eliminating the need for multiple trays. The system features IoT connectivity, AI analytics, and real-time compliance monitoring, promising treatment completion in approximately half the time of conventional aligners. Survey data shows overwhelming patient interest, with 93% preferring overnight correction and 95% expressing interest in ZSmile's approach.
Dror Ortho-Design (OTC PINK: DROR) has successfully completed user experience trials for its ZSmile platform, a second-generation orthodontic solution. The trial evaluated the platform's usability among patients, orthodontists, and dental professionals under real operating conditions.
The company's first-generation system, FDA-cleared in 2020, has treated over 250 patients across Israel and Europe. The new ZSmile platform features remote monitoring and patient management capabilities, tracking treatment compliance in real-time. Dror plans to begin manufacturing and distribution in Israel in the first half of 2025, pending regulatory approval.
A third-party survey of 1,000 clear aligner patients revealed that 74% reported interference with daily activities, 77% experienced discomfort, and 93% preferred a nighttime solution for teeth alignment.
Dror Ortho-Design (OTC PINK: DROR) has announced a strategic partnership with Aran Research & Development to accelerate the development and commercialization of their ZSmile™ orthodontic treatment platform. Unlike traditional aligners using multiple plastic trays, ZSmile features a sophisticated control unit with silent air pump technology that delivers precise air pulses to a micro-balloon within their smart aligner.
The collaboration leverages Aran's expertise in electrical and mechanical engineering, electronics, materials science, industrial design, and manufacturing. This partnership eliminates the need for a large internal hardware development team while maintaining high product development standards. The companies are working together to establish robust production processes that meet FDA, CE, and ISO requirements for the upcoming commercial launch.
Dror Ortho-Design (OTC PINK: DROR) has released an updated investor presentation and video walkthrough on their website, highlighting their ZSmile platform. The company's proprietary solution uses pulsating air delivered through a single custom-made smart aligner to straighten teeth, primarily while patients sleep.
The ZSmile technology integrates AI capabilities through an app that enables dental professionals to remotely monitor and adjust treatment plans, reducing the need for office visits. The company aims to disrupt the traditional aligner market with this innovative approach.
Additionally, Dror filed a Form S-1 registration statement with the SEC on June 5, 2024, regarding the exchange of private shares for company shareholders.
Dror Ortho-Design (OTC PINK: DROR) has unveiled ZSmile, an innovative orthodontic solution using pulsating air through a single smart aligner for teeth straightening. The technology reduces plastic waste by up to 20 times compared to traditional aligners, which generate approximately 2.8 million kilograms of plastic waste annually. Traditional treatments require 10-20 aligners per patient, while ZSmile uses just one. The AI-powered system enables remote monitoring and promises treatment completion in half the time of conventional methods, while reducing in-office visits.
Dror Ortho-Design (OTC PINK: DROR) has launched a user experience trial for its ZSMILE platform, an AI-based orthodontic solution that straightens teeth using pulsating air delivered by a single custom-made smart aligner. The trial, conducted in Israel, involves eligible patients, orthodontists, and dental professionals. ZSMILE is designed to be used while sleeping or discreetly at home.
The company's first-generation solution received CE mark in 2013 and FDA 510k clearance in 2020, having treated over 250 patients in Israel and Europe. The second-generation ZSMILE includes a mobile app for patients to track progress and a patient management system for doctors, utilizing AI technology for remote monitoring and treatment plan adjustments.
Dror Ortho-Design (OTC PINK: DROR) has launched its new ZSMILE brand, replacing the former Aerodentis platform. ZSMILE is an AI-based orthodontic solution that uses a single smart aligner with pulsating air to straighten teeth while sleeping or at home. This innovative approach aims to revolutionize smile correction by offering a discreet and gentle alternative to traditional aligners.
The ZSMILE platform leverages AI technology to allow dentists and orthodontists to monitor and adjust treatment plans remotely, reducing the need for office visits. Dror's CEO, Lee Haddad, emphasized that ZSMILE aligns with their mission to provide convenient smile correction without the need for all-day plastic aligners.
Additionally, Dror's S-1 registration statement was declared effective by the SEC on June 14, 2024, with a final prospectus filed on June 17, 2024.
Summary not available.